Teplizumab: A Disease-Modifying Therapy for Type 1 Diabetes That Preserves beta-Cell Function. Herold KC, Gitelman SE, Gottlieb PA, Knecht LA, et al. Diabetes Care 2023 Aug 22:dc230675. doi: 10.2337/dc23-0675.

Read + Share

Amedeo Smart

Independent Medical Education

Herold KC, Gitelman SE, Gottlieb PA, Knecht LA, et al. Teplizumab: A Disease-Modifying Therapy for Type 1 Diabetes That Preserves beta-Cell Function. Diabetes Care 2023 Aug 22:dc230675. doi: 10.2337/dc23-0675.
PMID: 37607392